tirzepatide surmount 2 trial results once weekly for the treatment of obesity in people with type diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 Consistent improvements in liver histology – SURMOUNT-2: new advances for treating
Pay in 4 interest-free payments of $5.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1



01022-6/asset/419d8465-83ce-4d57-9972-6021e1483742/main.assets/gr2.jpg)

















